Filing Flows › Evolent Health (EVH) › Q3 2026
Evolent Health (EVH) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Evolent Health (EVH) reported revenue of $725M for the third quarter 2026 (Q3 2026), +51% from a year earlier and +11% from the quarter before. Operating margin was -0.9%, net loss $23.6M (3.2% of revenue).
Evolent Health, Q3 2026: revenue $725M (+51% year over year), operating margin -0.9%, net loss $23.6M, operating cash flow $26.4M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $725M | +11% | +51% |
| Operating profit | −$6.2M | — | -798% |
| Net earnings | −$23.6M | — | — |
| Operating cash flow | $26.4M | — | +67% |
What changed
Revenue was $725.4M in Q3 2026, up 51% year over year and up 11% from the previous quarter.
Operating costs exceeded revenue by $6.2M, an operating margin of -0.9%. Total costs grew 53% against revenue growth of 51%. The fastest-growing cost line was Cost of revenue (+68%). The quarter ended with a net loss of $23.6M, narrower than the previous quarter's $28.4M loss. Net interest and other expense of $16.3M was the main reason.
Operating cash flow was $26.4M (up 67% year over year). Non-cash charges added back $21.5M of depreciation and amortization and $14.8M of share-based compensation. Working capital and other items added $13.6M.
Questions
What was Evolent Health's revenue in the third quarter 2026?
Evolent Health (EVH) reported revenue of $725M for the third quarter 2026 (Q3 2026), +51% from a year earlier and +11% from the quarter before.
Was Evolent Health profitable in the third quarter 2026?
Operating loss was $6.2M (-0.9% of revenue) and net loss $23.6M.
Source: Evolent Health 10-Q on SEC EDGAR.